Search results
Results from the WOW.Com Content Network
Albendazole is a broad-spectrum antihelmintic and antiprotozoal agent of the benzimidazole type. [3] It is used for the treatment of a variety of intestinal parasite infections, including ascariasis, pinworm infection, hookworm infection, trichuriasis, strongyloidiasis, taeniasis, clonorchiasis, opisthorchiasis, cutaneous larva migrans, giardiasis, and gnathostomiasis, among other diseases.
The treatment is just an antibiotic, and most puppies do fine after medication, but you do need to take your puppy to your local veterinarian so that the stool can be examined under a microscope.
Metronidazole is an antibiotic with an off-label use in eradicating H. pylori for treating gastric ulceration. Resistance of metronidazole is above 15% worldwide. [ 32 ] It is likely to be resistant so is not the first line choice of treatment. [ 44 ]
Mice and frogs can also infect the dog as collective hosts. The larvae hatch in the stomach, attach directly to the mucosa, and molt into adults (sexually mature worms). [24] The stomach worms cause damage to the gastric mucosa, leading to gastritis, bleeding and chronic vomiting. [25] In severe infection, weight loss and anemia occur.
Dogs with a bacterial infection feel an increased need to urinate. Some dogs will have dark urine or other signs of illness and, when treated with antibiotics and other treatments, this can clear ...
The success of H. pylori cure depends on the type and duration of therapy, patient compliance and bacterial factors such as antibiotic resistance. Patients most often fail to respond to initial H. pylori eradication therapy because of noncompliance or antibiotic resistance. Patients should be queried about any side effects, missed doses, and ...
The United States Food and Drugs Administration is warning pet owners about a common medication given to pets to treat arthritis. The F.D.A. now says that the drug Librela may be associated with ...
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]